KEGG   DRUG: Yttrium Y 90 labetuzumab tetraxetan
Entry
D06351                      Drug                                   
Name
Yttrium Y 90 labetuzumab tetraxetan (USAN)
Efficacy
Antineoplastic, Radioactive agent, Anti-CEA antibody
  Type
Antibody-drug conjugate
Comment
Radioimmunotherapy (RAIT) for CEA-expressing tumors in colorectal, pancreatic, lung, breast, ovarian, and medullary thyroid cancer
Target
CEACAM [HSA:1048 1084 1087 1088 1089 4680 634 90273] [KO:K06499]
Brite
Target-based classification of drugs [BR:br08310]
 Cell surface molecules and ligands
  Cell adhesion molecules: Ig superfamiy
   CAMs
    CEACAM
     D06351  Yttrium Y 90 labetuzumab tetraxetan (USAN)
Other DBs
CAS: 501423-30-9
PubChem: 47208008
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system